Intuitive Surgical is a US medical technology company and pioneer of surgical robots. With the da Vinci system, surgeons perform minimally invasive procedures, for example in urology, gynecology and general surgery. Revenue also comes from instruments and service per procedure. As of Oct 11, 2026
Intuitive Surgical offers robotic-assisted systems, instruments and accessories, training and customer service, connected through digital offerings. These include the da Vinci surgical system and Ion for bronchoscopy, for example for biopsy of small lung nodules. A network of field service engineers handles installation, repair, maintenance, round-the-clock technical support and predictive monitoring of the systems. In addition, there are digital services such as the My Intuitive app, the My Intuitive+ subscription and data analytics for hospitals. The systems are used, for example, in gallbladder removal, hernia surgery and colorectal procedures.
Automatically summarized from SEC annual report (10-K, filed Feb 3, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026
Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
No buy zone
There is currently no buy zone for this symbol under our Elliott rule. One only forms when the price pulls back after a strong rise.
An observation, not investment advice
Rule (4-hour candles) No active buy zone – the last one ended on Oct 22, 2026 · Buy zone no longer valid Zone historyThe zone history shows since when a buy zone has applied, when it was adjusted and when the price touched or left it. Recording began on Oct 12, 2026, only runs forward and fills nothing in – older zones are marked “known at start of recording” or “already existing when added”.Example: New buy zone on Oct 14, no adjustment since → “zone valid since Oct 14, 2026 · unchanged since”.More in the Academy: Lesson buy zone and Fibonacci
Watcher Full history: every change of the buy zone with its date.
Weekly candles (1W) No entry in the zone history yet (recording since Oct 12, 2026). Zone historyThe zone history shows since when a buy zone has applied, when it was adjusted and when the price touched or left it. Recording began on Oct 12, 2026, only runs forward and fills nothing in – older zones are marked “known at start of recording” or “already existing when added”.Example: New buy zone on Oct 14, no adjustment since → “zone valid since Oct 14, 2026 · unchanged since”.More in the Academy: Lesson buy zone and Fibonacci
Timeframe 1 week · As of Oct 23, 2026 · display only, the rule works on 4-hour candles
Elliott count: Zigzag (A-B-C), Corrective pattern (upward), C in progress (4 of 4 guidelines) · B = 76% of A; C = 135% of A
smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart.
Position: Correction after impulse 1–5 (count up or down before it)
Alternative (not drawn): Impulse, Impulse pattern (upward), Wave 3 in progress (2 of 2 guidelines)
Before (drawn faintly): Impulse (W5 extended), Wave 5 complete
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
No buy zone of the rule on this timeframe – the chart shows only the Elliott count from the completed weekly candles (recalculated every day). Not a recommendation, not investment advice. Without a buy zone there is no reference for percentages – so no value axis and no prices; measurements are ratios of wave lengths.
Timeframe 1 day · As of Oct 27, 2026 · display only, the rule works on 4-hour candles
Elliott count: Combination (W-X-Y-X-Z), Corrective pattern (upward), Z in progress (4 of 4 guidelines) · X = 39% of W; Y = 72% of W; X = 81% of Y; Z = 63% of W–Y
smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart.
Alternative (not drawn): Nested combination, Corrective pattern (upward), Y in progress (3 of 3 guidelines)
Note: Structure open: leg X, X cannot be broken down into sub-waves on this timeframe – provisional, check the count yourself on the chart.
Note: Retracement at least 88.7% of A: flat possible (B in progress, type only with C).
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
No buy zone of the rule on this timeframe – the chart shows only the Elliott count from the completed daily candles (recalculated every day). Not a recommendation, not investment advice. Without a buy zone there is no reference for percentages – so no value axis and no prices; measurements are ratios of wave lengths.
Timeframe 4 hours · As of Oct 27, 2026
Elliott count: Nested combination, Corrective pattern (upward), Y in progress (3 of 3 guidelines) · X = 80% of W; Y = 117% of W
smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart.
Alternative (not drawn): Zigzag (A-B-C), Corrective pattern (upward), C in progress (2 of 3 guidelines)
Note: Nested: leg W is itself a combination, its X is 38.0% (at most 88.7%).
Note: Structure ambiguous: leg W can also be read as three- or five-part.
Note: Structure open: leg X cannot be broken down into sub-waves on this timeframe – provisional, check the count yourself on the chart.
Note: Retracement at least 88.7% of A: flat possible (B in progress, type only with C).
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
No buy zone of the rule on this timeframe – the chart shows only the Elliott count from the completed 4-hour candles (recalculated every hour). Not a recommendation, not investment advice. Without a buy zone there is no reference for percentages – so no value axis and no prices; measurements are ratios of wave lengths.
Timeframe 1 hour · As of Oct 27, 2026 · display only, the rule works on 4-hour candles
Elliott count: Flat (type known only after C), Corrective pattern (upward), C in progress (1 of 3 guidelines) · B = 158% of A; C = 230% of A
Note: Flat type (regular, expanded, running) can only be decided once C is complete.
Note: Structure ambiguous: leg A can also be read as three- or five-part.
Note: Retracement at least 88.7% of A: flat possible (B in progress, type only with C).
Elliott count calculated automatically by fixed Elliott rules, not investment advice – display only, our buy zones do not use it. Provisional: The count can change with new candles.
No buy zone of the rule on this timeframe – the chart shows only the Elliott count from the completed hourly candles (recalculated every hour). Not a recommendation, not investment advice. Without a buy zone there is no reference for percentages – so no value axis and no prices; measurements are ratios of wave lengths.
Timeframe 1 week · As of Oct 23, 2026 · from the Elliott count in the analysis chart
Weighting Main scenario: ahead (4 of 4 guidelines, strong) · Alternative: behind (2 of 2, strong) Guidelines (strength of the count)Guidelines are typical features of a count, such as usual Fibonacci lengths or a change in the form of correction. Strong means: at least three quarters met, medium: at least half, otherwise weak. Even a strong count can flip.Example: 3 of 3 guidelines → strong; 2 of 4 → medium; 1 of 3 → weak.More in the Academy: Lesson wave degrees
Weighting by guidelines met – not a probability.
smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart.
As long as the weekly close stays above the end of B, this applies: sharp countermove upward in three waves (Zigzag A-B-C), C in progress – count points to rising prices.
Invalid if the weekly close is below the end of B
If that breaks, the alternative moves to the front: Upward move in five waves (Impulse) – count points to rising prices, as long as the weekly close stays above the start of wave 1.
Invalid if the weekly close is below the start of wave 1
Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.
Timeframe 1 day · As of Oct 27, 2026 · from the Elliott count in the analysis chart
Weighting Main scenario: ahead (4 of 4 guidelines, strong) · Alternative: behind (3 of 3, strong) Guidelines (strength of the count)Guidelines are typical features of a count, such as usual Fibonacci lengths or a change in the form of correction. Strong means: at least three quarters met, medium: at least half, otherwise weak. Even a strong count can flip.Example: 3 of 3 guidelines → strong; 2 of 4 → medium; 1 of 3 → weak.More in the Academy: Lesson wave degrees
Weighting by guidelines met – not a probability.
smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart. No visible sub-waves in: X.
As long as the daily close stays above the end of the second X, this applies: complex countermove upward (Combination W-X-Y-X-Z), Z in progress – count points to rising prices.
Invalid if the daily close is below the end of the second X
If that breaks, the second reading no longer applies either: complex countermove upward (Nested combination), Y in progress – then there is no valid count for now; the next candles will produce a new one.
Invalid if the daily close is below the end of X
Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.
Timeframe 4 hours · As of Oct 27, 2026 · from the Elliott count in the analysis chart
Weighting Main scenario: ahead (3 of 3 guidelines, strong) · Alternative: behind (2 of 3, medium) Guidelines (strength of the count)Guidelines are typical features of a count, such as usual Fibonacci lengths or a change in the form of correction. Strong means: at least three quarters met, medium: at least half, otherwise weak. Even a strong count can flip.Example: 3 of 3 guidelines → strong; 2 of 4 → medium; 1 of 3 → weak.More in the Academy: Lesson wave degrees
Weighting by guidelines met – not a probability.
smaller wave degree Smaller wave degree: more sensitive turning-point detection, because no count fits at the usual degree – it describes shorter swings. Provisional – check the count yourself on the chart. No visible sub-waves in: X.
As long as the 4-hour close stays above the end of X, this applies: complex countermove upward (Nested combination), Y in progress – count points to rising prices.
Invalid if the 4-hour close is below the end of X
If that breaks, the second reading no longer applies either: sharp countermove upward in three waves (Zigzag A-B-C), C in progress – then there is no valid count for now; the next candles will produce a new one.
Invalid if the 4-hour close is below the end of B
Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.
Timeframe 1 hour · As of Oct 27, 2026 · from the Elliott count in the analysis chart
Weighting Main scenario (1 of 3 guidelines, weak) · no alternative Guidelines (strength of the count)Guidelines are typical features of a count, such as usual Fibonacci lengths or a change in the form of correction. Strong means: at least three quarters met, medium: at least half, otherwise weak. Even a strong count can flip.Example: 3 of 3 guidelines → strong; 2 of 4 → medium; 1 of 3 → weak.More in the Academy: Lesson wave degrees
Weighting by guidelines met – not a probability.
As long as the hourly close stays above the end of B, this applies: flat countermove upward in three waves (Flat, type known only after C), C in progress – count points to rising prices.
Invalid if the hourly close is below the end of B
If that breaks, this count no longer applies. Currently no alternative that follows the rules.
Watcher Fibonacci target zones and levels for this count – as a help for your own review – from Watcher.
Intuitive Surgical · Sector Health Care · amounts in USD
Information only – does not affect the other analysis methods, not investment advice. Source: SEC filings, As of Feb 3, 2026.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
Fiscal year to Dec 31, 2025
66.0% Fiscal year 2025
Rank 73 of 100: higher than 73% of 153 peers (All). strong.
Rank 48 of 100: higher than 48% of 20 peers (Sector). medium.
Median Health Care: 66.6%
Share of revenue left after the direct cost of the products sold.
29.3% Fiscal year 2025
Rank 77 of 100: higher than 77% of 192 peers (All). strong.
Rank 83 of 100: higher than 83% of 20 peers (Sector). strong.
Median Health Care: 18.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
28.4% Fiscal year 2025
Rank 81 of 100: higher than 81% of 237 peers (All). strong.
Rank 75 of 100: higher than 75% of 26 peers (Sector). strong.
Median Health Care: 13.9%
Profit after all costs, interest and taxes divided by revenue.
16.0% Fiscal year 2025
Rank 49 of 100: higher than 49% of 218 peers (All). medium.
Rank 64 of 100: higher than 64% of 21 peers (Sector). medium.
Median Health Care: 14.3%
Net income divided by equity at fiscal year end.
14.0% Fiscal year 2025 (total assets at year end)
Rank 83 of 100: higher than 83% of 238 peers (All). strong.
Rank 83 of 100: higher than 83% of 26 peers (Sector). strong.
Median Health Care: 6.4%
Net income divided by total assets at fiscal year end.
87.1% Fiscal year 2025
Rank 97 of 100: higher than 97% of 239 peers (All). strong.
Rank 98 of 100: higher than 98% of 26 peers (Sector). strong.
Median Health Care: 38.5%
Equity as a share of total assets. Usually low for banks.
24.7% Fiscal year 2025
Rank 77 of 100: higher than 77% of 213 peers (All). strong.
Rank 78 of 100: higher than 78% of 25 peers (Sector). strong.
Median Health Care: 14.9%
Free cash flow divided by revenue.
2.5B USD Fiscal year 2025
Operating cash flow minus capital expenditure on property and equipment.
+17.4% per year
Rank 73 of 100: higher than 73% of 230 peers (All). strong.
Rank 90 of 100: higher than 90% of 25 peers (Sector). strong.
Median Health Care: +5.6%
Average growth per year over 3 fiscal years.
+18.2% per year
Rank 70 of 100: higher than 70% of 217 peers (All). strong.
Rank 82 of 100: higher than 82% of 25 peers (Sector). strong.
Median Health Care: +8.5%
Average growth per year over 5 fiscal years.
+15.5% per year
Rank 82 of 100: higher than 82% of 157 peers (All). strong.
Rank 82 of 100: higher than 82% of 19 peers (Sector). strong.
Median Health Care: +10.1%
Average growth per year over 10 fiscal years.
+29.2% per year
Rank 81 of 100: higher than 81% of 157 peers (All). strong.
Rank 93 of 100: higher than 93% of 22 peers (Sector). strong.
Median Health Care: +5.5%
Growth of earnings per share per year, adjusted for stock splits.
+21.8% per year
Rank 72 of 100: higher than 72% of 146 peers (All). strong.
Rank 88 of 100: higher than 88% of 20 peers (Sector). strong.
Median Health Care: +7.0%
Growth of earnings per share per year, adjusted for stock splits.
+16.4% per year
Rank 77 of 100: higher than 77% of 140 peers (All). strong.
Rank 78 of 100: higher than 78% of 20 peers (Sector). strong.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
5 of 8 Fiscal year 2025
No rank: not all 9 criteria have data.
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
4.87 at fiscal year end
Rank 90 of 100: higher than 90% of 215 peers (All). strong.
Rank 94 of 100: higher than 94% of 26 peers (Sector). strong.
Median Health Care: 1.56
Current assets divided by current liabilities.
+0.5% in 5 years
Rank 39 of 100: lower than 39% of 199 peers (All). medium.
Rank 23 of 100: lower than 23% of 24 peers (Sector). weak.
Median Health Care: −2.7%
Change in diluted share count. Negative = share buybacks, positive = new shares.
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
No reported values for “Dividend per share” in this interval.
No reported values for “Dividend per share” in this interval.
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 10.1B USD · Net income 2.9B USD · Net margin 28.4%
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Of 100 USD of revenue, 66.0 USD gross profit, 29.3 USD operating income and 28.4 USD net income remained.
| Item | Amount | of revenue |
|---|---|---|
| Revenue | 10.1B USD | 100.0% |
| Gross profit | 6.6B USD | 66.0% |
| Cost of revenue | 3.4B USD | 34.0% |
| Operating income | 2.9B USD | 29.3% |
| Research & development | 1.3B USD | 13.0% |
| Other operating expenses | 2.4B USD | 23.7% |
| Net income | 2.9B USD | 28.4% |
| Taxes, interest & other (net) | 89.5M USD | 0.9% |
Taxes, interest and other items are not available separately in the SEC data; they are combined as the difference.
The operating margin rose in 5 years from 24.1% to 29.3%.
Gross marginOperating marginNet marginReturn on equity rose in 5 years from 10.9% to 16.0%.
Return on equityReturn on assetsThe equity ratio stayed roughly the same in 5 years (87.1%).
Equity in USD Long-term debt, depending on the filing, includes the current portion or leases.The current ratio fell in 5 years from 6.86 to 4.87.
Current ratioFree cash flow rose in 5 years from 1.1B USD to 2.5B USD.
Operating cash flowCapital expenditureFree cash flow in USDThe share count stayed roughly the same in 5 years.
Diluted share countFrom annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Over 5 years, 5.3B USD went back to shareholders, 100% of it through share repurchases. That is 73% of the free cash flow of those years.
Dividends paidShare repurchasesNew shares issued (including employee plans)Free cash flow in USDDividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users. Log in
Intuitive Surgical next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
| Symbol | Revenue (FY) | Growth 5 yrs | Gross margin | Op. margin | Net margin | ROE | Equity ratio | FCF margin | Piotroski |
|---|---|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | 44.3B USD | +5.1% | 56.4% | 18.2% | 14.7% | 12.5% | 60.1% | 16.7% | 6/9 |
| AMGN Amgen | 36.8B USD | +7.6% | 67.2% | 24.7% | 21.0% | 89.1% | 9.6% | 22.0% | 7/9 |
| MDT Medtronic | 36.4B USD | +3.8% | 65.0% | 17.8% | 13.2% | 9.7% | 53.2% | 14.9% | 7/9 |
| GILD Gilead Sciences | 29.4B USD | +3.6% | 78.8% | 34.0% | 28.9% | 37.5% | 38.5% | 32.1% | 8/9 |
| SYK Stryker Corporation | 25.1B USD | +11.8% | 64.0% | 19.5% | 12.9% | 14.5% | 46.9% | 17.1% | 6/9 |
| DHR Danaher Corporation | 24.6B USD | +2.0% | 59.1% | 19.1% | 14.7% | 6.9% | 62.9% | 21.4% | 7/9 |
| REGN Regeneron Pharmaceuticals | 14.3B USD | +11.0% | – | 24.9% | 31.4% | 14.4% | 77.1% | 28.4% | – |
| VRTX Vertex Pharmaceuticals | 12.0B USD | +14.1% | 86.2% | 34.8% | 32.9% | 21.2% | 72.8% | 26.6% | – |
| ISRG Intuitive Surgical this stock | 10.1B USD | +18.2% | 66.0% | 29.3% | 28.4% | 16.0% | 87.1% | 24.7% | – |
| Median of the sector 26 symbols | 44.4B USD | +8.5% | 66.6% | 18.0% | 13.9% | 14.3% | 38.5% | 14.9% | 7/9 |
Growth 5 yrs = revenue growth per year over 5 fiscal years · Op. margin = operating margin · ROE = return on equity · FCF = free cash flow · Piotroski = F-Score (only with all 9 criteria).
Figures of the last fiscal year from SEC annual reports (peers as of Oct 28, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
+18.2% per year, last 5 years
Sector Health Care: median +7.8% (60 symbols)
What does this mean? Revenue: over 5 years it grew by 18.2% per year on average – at least as fast as the median company in the sector (+7.8%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
+21.9% per year, last 5 years
Sector Health Care: median +7.5% (46 symbols)
per share: +21.8% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 21.9% per year on average – at least as fast as the median company in the sector (+7.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
28.4% last fiscal year
Sector Health Care: median 12.9% (63 symbols)
What does this mean? Of every 100 USD in revenue, 28.38 USD remained as profit – at least as much as the median company in the sector (12.9%). Five years ago the margin was 24.3%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
– latest balance sheet
Sector Health Care: median 0.66 (49 symbols)
What does this mean? No usable figure: reported financial debt or positive equity for the same balance sheet date is missing.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
– Dividend / earnings per share
Sector Health Care: median 28% (31 symbols)
What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
10 of 10 fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
| Year | End | Revenue | Net income | Margin | Earnings per share | Dividend per share | Payout |
|---|---|---|---|---|---|---|---|
| 2025 | Dec 31, 2025 | 10.1B | 2.9B | 28.4% | 7.87 | – | – |
| 2024 | Dec 31, 2024 | 8.4B | 2.3B | 27.8% | 6.42 | – | – |
| 2023 | Dec 31, 2023 | 7.1B | 1.8B | 25.2% | 5.03 | – | – |
| 2022 | Dec 31, 2022 | 6.2B | 1.3B | 21.3% | 3.65 | – | – |
| 2021 | Dec 31, 2021 | 5.7B | 1.7B | 29.9% | 4.66 | – | – |
| 2020 | Dec 31, 2020 | 4.4B | 1.1B | 24.3% | 2.94 | – | – |
| 2019 | Dec 31, 2019 | 4.5B | 1.4B | 30.8% | 3.85 | – | – |
| 2018 | Dec 31, 2018 | 3.7B | 1.1B | 30.3% | 3.16 | – | – |
| 2017 | Dec 31, 2017 | 3.1B | 660.0M | 21.0% | 1.89 | – | – |
| 2016 | Dec 31, 2016 | 2.7B | 735.9M | 27.2% | 2.08 | – | – |
| Quarter | End | Revenue | Net income | Margin | Earnings per share | Dividend per share | Payout |
|---|---|---|---|---|---|---|---|
| Q3/26 | Sep 30, 2026 | 3.0B | 522.8M | 17.1% | 1.49 | – | – |
| Q2/26 | Jun 30, 2026 | 2.9B | 818.1M | 28.3% | 2.29 | – | – |
| Q1/26 | Mar 31, 2026 | 2.8B | 821.5M | 29.6% | 2.28 | – | – |
| Q4/25* | Dec 31, 2025 | 2.9B | 794.8M | 27.7% | – | – | – |
| Q3/25 | Sep 30, 2025 | 2.5B | 704.4M | 28.1% | 1.95 | – | – |
| Q2/25 | Jun 30, 2025 | 2.4B | 658.4M | 27.0% | 1.81 | – | – |
| Q1/25 | Mar 31, 2025 | 2.3B | 698.4M | 31.0% | 1.92 | – | – |
| Q4/24* | Dec 31, 2024 | 2.4B | 685.7M | 28.4% | – | – | – |
| Q3/24 | Sep 30, 2024 | 2.0B | 565.1M | 27.7% | 1.56 | – | – |
| Q2/24 | Jun 30, 2024 | 2.0B | 526.9M | 26.2% | 1.46 | – | – |
| Q1/24 | Mar 31, 2024 | 1.9B | 544.9M | 28.8% | 1.51 | – | – |
| Q4/23* | Dec 31, 2023 | 1.9B | 606.2M | 31.4% | – | – | – |
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Per-share values adjusted for stock split Stock splitA company divides each share into several new ones; the value of the company stays the same. We convert per-share values from before the split to today’s scale.Example: Split 4 : 1, earnings per share before $11.89 → comparable today $2.97.More in the Academy: Lesson revenue, profit and margin 3:1 (between Jul 21, 2017 and Oct 20, 2017), 3:1 (between Jul 21, 2021 and Oct 20, 2021). Quarters are labeled by the calendar quarter in which they end.
| Period | Purchases | Sales | Net |
|---|---|---|---|
| 3 months | $00 people | $16.9M7 people | −$16.9M |
| 6 months | $00 people | $20.0M8 people | −$20.0M |
| 12 months | $00 people | $70.9M11 people | −$70.9M |
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.
Latest news
No posts on ISRG yet – log in to join the discussion.
Posts are opinions of users and only visible after logging in. Community rules